Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty.
about
Stress echocardiography in heart failureAppropriateness criteria for cardiovascular imaging use in heart failure: report of literature reviewThe cardiac magnetic resonance (CMR) approach to assessing myocardial viabilityFull recovery of contraction late after acute myocardial infarction: determinants and early predictorsLow dose dobutamine echocardiography for predicting functional recovery after coronary revascularisationRelation between regional function and coronary blood flow reserve in multivessel coronary artery stenosis.Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.Low-dose dobutamine stress and left ventricular wall motion monitored with transesophageal echocardiography versus hemodynamic data derived from pulmonary artery catheterization in patients scheduled for CABG.Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease.Reversible congestive heart failure caused by myocardial hibernationReduced force production during low blood flow to the heart correlates with altered troponin I phosphorylationPathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viabilityCardiac imaging after myocardial infarction.Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy.Dobutamine echocardiography for detection of viable myocardium in ischemic cardiomyopathy.Diagnostic and prognostic use of stress echocardiography in stable patients.Reversible left ventricular dysfunction.Myocardial hibernation in coronary artery disease.Noninvasive assessment myocardial viability: current status and future directions.Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis.Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.Efficacy of coronary angioplasty for the treatment of hibernating myocardium.Concordance between dobutamine Doppler tissue imaging echocardiography and rest reinjection thallium-201 tomography in dysfunctional hypoperfused myocardiumDobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisationOutcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.Evidence for an active inflammatory process in the hibernating human myocardiumAssessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction.Assessment of myocardial viability by cardiovascular magnetic resonance.Hibernating myocardium in heart failure.Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.Diagnostic and imaging considerations: role of viability.Role of imaging in the detection of reversible cardiomyopathy.Impaired coronary flow reserve is the most important marker of viable myocardium in the myocardial segment-based analysis of dual-isotope gated myocardial perfusion single-photon emission computed tomography.Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.Myocardial reverse remodeling.Stress echocardiography for the detection and assessment of coronary artery disease.Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.The role of cardiac magnetic resonance imaging following acute myocardial infarction.Assessing the available techniques for testing myocardial viability: what does the future hold?
P2860
Q24800869-5974AFC2-42D0-4EFF-8A64-E38BA575A395Q26992237-62121024-577B-4B22-80D8-7E85226E2EEBQ27014679-5DC1DCA4-3013-4E61-AC4B-282C2D006252Q28362652-EAFFB6EA-12AC-4030-B321-C1AF6A693C36Q28364289-A622BA51-761E-4E1C-B6B2-685B58EDBDE8Q30306431-7905CCC7-32D3-4BC3-9BE8-B929B9CEA33FQ30439253-0201EA2D-05F3-4E64-81A5-3C8960895F07Q30666723-736112F6-E82A-4C09-AF50-56EE6DF2F5CCQ33432746-7238C5AD-A433-4FF4-A447-68C7D1956922Q33601833-7B0F41E2-FE37-4B70-8FDE-C9F823254D59Q33641335-783B5BB1-38EF-4D08-B224-9FB491B9D6A6Q33759444-A5D21C8A-83DA-4824-9F5A-DECFAEB1C066Q33773173-E3CD62EC-E922-4A95-B921-8F8473C33F4CQ34026372-F6DFBAB2-9CD7-4D0F-9883-C1844D7A502AQ34026377-006C3079-4EB4-4BC5-8EF9-62B883E954A9Q34026473-97B7A0D6-053E-4FF6-84AB-CE5A8D712075Q34026485-0FDC23F3-59A4-450F-83DD-5291BD72303DQ34514077-59AEA901-3ED0-4437-B217-71FCE42C3864Q34774619-F987546D-1FC4-4367-AF89-FAEB87CAAED6Q35101166-FB512896-966C-4633-88C5-F9A435AE08BDQ35366928-3D31A3F6-8292-4BBA-8369-D9D302EAF546Q35373426-693DCCD9-526B-494C-A964-DA94B2AFE5E3Q35565887-5DB0D582-497E-48D3-B21A-C88276CC4B2BQ35579861-A6E96A99-5DD4-4B51-8B3E-7EFBC4067B23Q35771303-8EA69E12-A096-43C3-A54F-7AB8E4C762E7Q35773117-1E0F9A1B-57FA-4B66-AC81-FFF456753D2BQ35788998-E2BFBB1F-EE7E-4513-BC67-60EF6E565E8FQ36014890-2B11A86C-522F-49E1-A79D-B2D8C77D5B96Q36031584-61E1F01A-BA6D-4ACE-ADCA-FC62C03DB792Q36050499-26AAF816-1CE9-4617-9442-E02D5DF4EB17Q36544287-0E6A3A15-B704-4BBA-B3B0-3A8902CFCD39Q36579484-16D6F517-6C37-4454-91CB-A883636B5E94Q36983228-591AA8C2-D253-4432-83B5-620FAE9E60BDQ37640164-5E176808-69EA-461D-8A31-E6EAB5365DB0Q37766159-CC3D9BC8-1B03-41D1-84DF-1C12C52584FEQ37812403-DF8BCAEE-00B0-467D-8DDA-397B9FAC01FBQ37856914-53AF7CBA-5D9A-497E-B82D-BD63295AD11EQ37974592-4A9E679F-6B3E-4878-BDE0-B379AD786960Q37996927-477F9EC1-04C2-4BCC-9CA6-A945D4A5E887Q38062030-93207454-B07F-4EC0-8471-F27B122A997F
P2860
Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Dobutamine echocardiography in ...... on after coronary angioplasty.
@en
Dobutamine echocardiography in ...... on after coronary angioplasty.
@nl
type
label
Dobutamine echocardiography in ...... on after coronary angioplasty.
@en
Dobutamine echocardiography in ...... on after coronary angioplasty.
@nl
prefLabel
Dobutamine echocardiography in ...... on after coronary angioplasty.
@en
Dobutamine echocardiography in ...... on after coronary angioplasty.
@nl
P2093
P356
P1433
P1476
Dobutamine echocardiography in ...... on after coronary angioplasty.
@en
P2093
P304
P356
10.1161/01.CIR.91.3.663
P407
P577
1995-02-01T00:00:00Z